Want to join the conversation?
$IRM currently estimates total OpEx and CapEx associated with the Recall transaction to be approx. $380MM, the majority of which is expected to be incurred by 2018-end. This amount consists of approx. $80MM of Recall deal close costs and approx. $300MM of Recall integration costs.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.